These tumors include IDH-wildtype glioblastoma (GBM) and IDH-mutant astrocytomas with grade 4 histologic features, as redefined in the 2021 WHO CNS tumor classification [2]. The gene discussed is IDH2; the disease is central nervous system neoplasm.